The Misuse of Drugs (Designation) (Amendment) Order 2005

JurisdictionUK Non-devolved
CitationSI 2005/1652
Year2005

2005 No. 1652

DANGEROUS DRUGS

The Misuse of Drugs (Designation) (Amendment) Order 2005

Made 22th June 2005

Laid before Parliament 23th June 2005

Coming into force 18th July 2005

The Secretary of State, in exercise of the powers conferred upon him by section 7(4) and (5) of the Misuse of Drugs Act 19711, on the recommendation of the Advisory Council on the Misuse of Drugs in accordance with section 7(7) of that Act, hereby makes the following Order:

S-1 Citation and commencement

Citation and commencement

1. This Order may be cited as the Misuse of Drugs (Designation) (Amendment) Order 2005 and shall come into force on 18th July 2005.

S-2 Amendment of the Misuse of Drugs (Designation) Order 2001

Amendment of the Misuse of Drugs (Designation) Order 2001

2. In Part 1 of the Schedule to the Misuse of Drugs (Designation) Order 20012, after “Etryptamine” insert “Fungus (of any kind) which contains psilocin or an ester of psilocin”.

Paul Goggins

Parliamentary Under Secretary of State

Home Office

22nd June 2005

(This note is not part of the Order)

Section 7(3) of the Misuse of Drugs Act 1971 (“the 1971 Act”) requires regulations to be made to allow the use for medical purposes of the drugs which are subject to control under the 1971 Act. Section 7(3) does not apply to any drug which is designated by order under section 7(4) as a drug to which section 7(4) is to apply. This Order amends the Misuse of Drugs (Designation) Order 2001, which was made under section 7(4) and (5) of the 1971 Act, by inserting into Part 1 of the Schedule to that Order a fungus of any kind which contains psilocin or an ester of psilocin (commonly known as magic mushrooms) and thereby designates such a fungus for the purposes of section 7(4) of the 1971 Act.


To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT